2019
DOI: 10.1016/j.enzmictec.2019.05.010
|View full text |Cite
|
Sign up to set email alerts
|

Novel xylanolytic triple domain enzyme targeted at feruloylated arabinoxylan degradation

Abstract: releasing soluble oligosaccharides that CE1 can utilize as substrate. CE1 also displayed activity towards solubilized 5-O-trans-feruloyl-α-L-Araf (kcat = 36.35 s-1). This suggests that CE1 preferably acts on soluble oligosaccharides.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 30 publications
2
11
0
Order By: Relevance
“…2A-B), but the properties and the topology of the active site pocket and the binding cleft are very different ( Fig. 8A-E BK010417.1) for which the above mentioned characteristics were previously described (22).…”
Section: The Role Of Cbm48 In Relation To Substrate Distortion To Assmentioning
confidence: 78%
“…2A-B), but the properties and the topology of the active site pocket and the binding cleft are very different ( Fig. 8A-E BK010417.1) for which the above mentioned characteristics were previously described (22).…”
Section: The Role Of Cbm48 In Relation To Substrate Distortion To Assmentioning
confidence: 78%
“…A unique feature has been reported for the first time from an exceptional metagenomic xylanase (UX66) that comprises two CBDs and two catalytic domains (Zhao et al, 2010). Another unique three catalytic domain multi-enzyme (a CE1 ferulic acid esterase, a GH62 α-L-arabinofuranosidase, and a GH10 β-D-1,4-xylanase) has been recovered from the metagenome of wastewater treatment sludge (Holck et al, 2019). Such attributes enhance the applicability of xylanase manifold over the xylanases having one single catalytic domain.…”
Section: Unusual Metagenomic Xylanolytic Enzymesmentioning
confidence: 99%
“…The electrospray was operated in negative mode with UltraScan mode and a scan range from 100 to 1000 m/z, smart parameter setting of 190 m/z, capillary voltage at 4.5 kV, endplate off-set 0.5 kV, nebulizer pressure at 3.0 bar, dry gas flow at 12.0 L/min, and dry gas temperature at 280 °C. CID fragmentation of deprotonated ions was performed by Multiple Reaction Monitoring using SmartFrag enhanced amplitude ramping from 80 to 120%, fragmentation time 20 ms. Quantification was performed in Compass QuantAnalysis 2.2 (Bruker Daltonics, Bremen Germany) using trans-ferulic acid as external standard and adjusted according to the internal standard as described previously [ 38 ].…”
Section: Methodsmentioning
confidence: 99%